MT-RNR2 and age-related macular degeneration: However, SHLP2 + amyloid-β42–1 SC–treated AMD cybrids showed significant increase in mtGFP staining intensity compared to the AMD cybrids treated with amyloid-β42–1 SC alone (83.81%; AMD amyloid-β42–1SC: 0.